Condition Guide

Peptides for Anti-Aging & Longevity

Longevity research has produced several peptide candidates that influence telomere biology, mitochondrial function, and the sirtuin pathway — all hallmarks of cellular aging.

Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.

How peptides help

Epithalon upregulates telomerase activity; MOTS-c activates AMPK and promotes mitochondrial biogenesis; NAD+ precursors support sirtuin-mediated longevity pathways. Evidence ranges from Russian cohort studies (Epithalon) to Phase I human trials (MOTS-c) to growing pilot data (NAD+ precursors).

Peptides researched for anti-aging & longevity

State of the evidence

Few longevity peptides have large Phase III outcome trials. Most evidence is mechanistic, preclinical, or from small cohorts. Claims of lifespan extension in humans remain unproven.

Frequently asked

Can peptides slow aging?

There is preclinical and limited pilot human evidence that some peptides affect aging biomarkers. Lifespan extension in humans is not yet proven and requires long-term controlled trials.

Related articles & guides

Related conditions